arginine has been researched along with Pseudomonas Infections in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (5.56) | 18.7374 |
| 1990's | 4 (22.22) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, Q; Huang, HB; Huang, LX; Qin, YX; Wang, XR; Yan, QP; Yuan, B; Zhao, LM; Zhuang, ZX | 1 |
| Beigverdi, R; Emaneini, M; Halimi, S; Jabalameli, F; Siroosi, M | 1 |
| Barrientos-Moreno, L; Espinosa-Urgel, M; Molina-Henares, MA; Ramos-González, MI | 1 |
| Ahmadi, S; Bear, CE; Di Paola, M; Khursigara, CM; Lam, JS; Park, AJ; Roach, EJ; Struder-Kypke, M; Wu, YS | 1 |
| Cutruzzolà, F; Giardina, G; Janson, G; Leoni, L; Mantoni, F; Paiardini, A; Paone, A; Rampioni, G; Rinaldo, S | 1 |
| Beloin, C; Chauhan, A; de Reuse, H; Fischer, F; Ghigo, JM; Lebeaux, D; Létoffé, S | 1 |
| Amábile-Cuevas, CF | 1 |
| Cai, Q; Everett, J; Gordon, V; Rumbaugh, K; Turner, K; Whiteley, M | 1 |
| Chiu, WC; Shang, HF; Tsai, HJ; Yeh, SL | 1 |
| Galkin, A; Herzberg, O; Howard, A; Kulakova, L; Lim, K; Sarikaya, E | 1 |
| Borriello, G; Ehrlich, GD; Richards, L; Stewart, PS | 1 |
| Gunning, Y; Hopkins, N; Laffey, JG; McLoughlin, P; O'Croinin, DF | 1 |
| Comeau, AM; Dorkin, HL; O'Sullivan, BP; Parad, R; Zwerdling, RG | 1 |
| Yamada, K | 1 |
| Bättig, U; Cakmakci, M; Geroulanos, S; Schilling, J | 1 |
| Li, HQ; Liu, R; Pan, J; Qin, SW; Shen, CK; Shi, Y; Wang, JH | 1 |
| McCormack, DG; Paterson, NA; Yaghi, A | 1 |
| McCormack, DG; Paterson, NA | 1 |
18 other study(ies) available for arginine and Pseudomonas Infections
| Article | Year |
|---|---|
Transcriptomic and metabolomic insights into the role of the
Topics: Animals; Arginine; Bacterial Proteins; Bass; Fish Proteins; Glycerophospholipids; Host-Pathogen Interactions; Immunity, Innate; Lectins, C-Type; Mitogen-Activated Protein Kinases; Perciformes; Pseudomonas; Pseudomonas Infections; Transcriptome; Virulence | 2022 |
Determining effects of nitrate, arginine, and ferrous on antibiotic recalcitrance of clinical strains of Pseudomonas aeruginosa in biofilm-inspired alginate encapsulates.
Topics: Alginates; Amikacin; Anti-Bacterial Agents; Arginine; Biofilms; Ciprofloxacin; Cystic Fibrosis; Humans; Microbial Sensitivity Tests; Nitrates; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2023 |
Arginine as an environmental and metabolic cue for cyclic diguanylate signalling and biofilm formation in Pseudomonas putida.
Topics: Arginine; Bacterial Proteins; Biofilms; Cyclic GMP; Gene Expression Regulation, Bacterial; Pseudomonas Infections; Pseudomonas putida | 2020 |
Topics: Amino Acid Transport Systems; Amino Acid Transport Systems, Neutral; Animals; Arginine; Bacterial Adhesion; Cystic Fibrosis; Epithelial Cells; Humans; Mice, Knockout; Plasma Membrane Neurotransmitter Transport Proteins; Pseudomonas aeruginosa; Pseudomonas Infections | 2017 |
A novel bacterial l-arginine sensor controlling c-di-GMP levels in Pseudomonas aeruginosa.
Topics: Amino Acid Sequence; Arginine; Bacterial Proteins; Cyclic GMP; Escherichia coli Proteins; Humans; Hydrolysis; Models, Molecular; Phosphoric Diester Hydrolases; Phosphorus-Oxygen Lyases; Protein Binding; Protein Domains; Pseudomonas aeruginosa; Pseudomonas Infections; Sequence Alignment | 2018 |
pH-mediated potentiation of aminoglycosides kills bacterial persisters and eradicates in vivo biofilms.
Topics: Animals; Anti-Bacterial Agents; Arginine; Biofilms; Catheter-Related Infections; Central Venous Catheters; Drug Synergism; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Gentamicins; Hydrogen-Ion Concentration; In Vitro Techniques; Pseudomonas aeruginosa; Pseudomonas Infections; Rats; Staphylococcal Infections; Staphylococcus aureus | 2014 |
Selection of Amikacin Hyper-Resistant Pseudomonas aeruginosa After Stepwise Exposure to High Amikacin Concentrations.
Topics: Aerosols; Amikacin; Anti-Bacterial Agents; Arginine; Biofilms; Biological Transport; Drug Resistance, Bacterial; Gene Expression; Genes, MDR; Humans; Microbial Sensitivity Tests; Phenotype; Pseudomonas aeruginosa; Pseudomonas Infections; Selection, Genetic | 2017 |
Arginine Is a Critical Substrate for the Pathogenesis of
Topics: Animals; Anti-Bacterial Agents; Arginine; Burns; Disease Models, Animal; Mice; Pseudomonas aeruginosa; Pseudomonas Infections; Survival Analysis; Treatment Outcome; Virulence; Wound Infection | 2017 |
Effects of dietary arginine supplementation on antibody production and antioxidant enzyme activity in burned mice.
Topics: Animals; Antibody Formation; Antioxidants; Arginine; Bacterial Vaccines; Burns; Diet; Glutathione Peroxidase; Male; Mice; Mice, Inbred BALB C; Pseudomonas aeruginosa; Pseudomonas Infections; Random Allocation; Superoxide Dismutase; T-Lymphocytes; Thiobarbituric Acid Reactive Substances | 2003 |
Structural insight into arginine degradation by arginine deiminase, an antibacterial and parasite drug target.
Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Arginine; Catalytic Domain; Crystallography; Drug Design; Humans; Hydrolases; Molecular Sequence Data; Parasites; Protein Structure, Tertiary; Pseudomonas aeruginosa; Pseudomonas Infections; Structure-Activity Relationship | 2004 |
Arginine or nitrate enhances antibiotic susceptibility of Pseudomonas aeruginosa in biofilms.
Topics: Anaerobiosis; Anti-Bacterial Agents; Arginine; Biofilms; Drug Synergism; Nitrates; Pseudomonas aeruginosa; Pseudomonas Infections; Tobramycin | 2006 |
Anti-inflammatory effect of augmented nitric oxide production in chronic lung infection.
Topics: Animals; Arginine; Bronchoalveolar Lavage Fluid; Cell Count; Chronic Disease; Disease Models, Animal; Enzyme Inhibitors; Interleukin-1; Interleukin-6; Lung; Lung Diseases; Male; Neutrophils; NG-Nitroarginine Methyl Ester; Nitric Oxide; Pseudomonas Infections; Rats; Rats, Inbred WKY; Tyrosine; Vascular Endothelial Growth Factor A | 2006 |
Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype.
Topics: Age of Onset; Arginine; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Female; Genotype; Histidine; Humans; Infant, Newborn; Lung Diseases; Male; Mutation, Missense; Neonatal Screening; Point Mutation; Pseudomonas aeruginosa; Pseudomonas Infections | 2006 |
A clinical trial of MD-805, a synthetic thrombin inhibitor, for the treatment of DIC.
Topics: Antithrombins; Arginine; Chemical Phenomena; Chemistry; Child; Disseminated Intravascular Coagulation; Female; Fibrinogen; Humans; Meningoencephalitis; Partial Thromboplastin Time; Pipecolic Acids; Platelet Count; Prothrombin Time; Pseudomonas Infections; Sepsis; Sulfonamides; Thrombin | 1983 |
A new approach in the treatment of hypotension in human septic shock by NG-monomethyl-L-arginine, an inhibitor of the nitric oxide synthetase.
Topics: Adult; Amino Acid Oxidoreductases; Arginine; Blood Pressure; Cardiac Output; Combined Modality Therapy; Critical Care; Dose-Response Relationship, Drug; Humans; Hypotension; Male; Necrosis; Nitric Oxide Synthase; omega-N-Methylarginine; Pancreatitis; Pseudomonas aeruginosa; Pseudomonas Infections; Recurrence; Shock, Septic; Staphylococcal Infections | 1993 |
Association between protective efficacy of antibodies to tumor necrosis factor and suppression of nitric oxide production in neonatal rats with fatal infection.
Topics: Animals; Animals, Newborn; Arginine; Bacteremia; Depression, Chemical; Dexamethasone; Isoantibodies; Nitrates; Nitric Oxide; Nitrites; omega-N-Methylarginine; Pseudomonas Infections; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 1993 |
Nitric oxide does not mediate the attenuated pulmonary vascular reactivity of chronic pneumonia.
Topics: Acetylcholine; Animals; Arginine; Chronic Disease; Male; Nitric Oxide; omega-N-Methylarginine; Pneumonia; Pseudomonas Infections; Pulmonary Circulation; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents | 1993 |
Loss of hypoxic pulmonary vasoconstriction in chronic pneumonia is not mediated by nitric oxide.
Topics: Animals; Arginine; Blood Pressure; Cardiac Output; Hemodynamics; Hypoxia; Inflammation; Muscle, Smooth, Vascular; Nitric Oxide; omega-N-Methylarginine; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Pulmonary Artery; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Vascular Resistance; Vasoconstriction | 1993 |